Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (16,918,477)	$ (14,847,380)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	4,074,458	432,321
Stock-based 401K company common match	35,747	19,967
Depreciation expense	5,357	15,608
Operating lease expense	241,031	160,684
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(99,904)	810,797
Accounts payable	(105,821)	217,504
Accrued expenses	452,382	637,682
Restructuring reserve	0	(498,185)
Operating lease liabilities	(170,839)	(98,133)
Net cash used in operating activities	(12,486,066)	(13,149,135)
Cash flows from financing activities:
Proceeds from exercise of warrants	0	70,459
Proceeds from exercise of stock options	344,125	0
Proceeds from issuances of common stock, net of issuance costs	48,544,998	29,756,502
Net cash provided by financing activities	48,889,123	29,826,961
Net increase in cash and cash equivalents	36,403,057	16,677,826
Cash and cash equivalents at beginning of period	28,839,565	12,161,739
Cash and cash equivalents at end of period	$ 65,242,622	$ 28,839,565